Colistin-mediated neurotoxicity

BMJ Case Reports

Volumn 2014, Issue , 2014, Pages

  Wadia, Subeer ^a   Tran, Betty ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; DORIPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; APNEA; ARTICLE; BRAIN STEM RESPONSE; CASE REPORT; COMA; CONVALESCENCE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; HUMAN; MALE; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEPHROTOXICITY; NEUROMUSCULAR BLOCKING; NEUROTOXICITY; PROTEUS MIRABILIS; SIDE EFFECT; SPUTUM CULTURE; VENTILATOR ASSOCIATED PNEUMONIA; BRAIN STEM; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY DISEASE; NEUROMUSCULAR DISEASE; NEUROTOXICITY SYNDROMES;

ANTI-BACTERIAL AGENTS; APNEA; BRAIN STEM; COLISTIN; COMA; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NEUROMUSCULAR DISEASES; NEUROTOXICITY SYNDROMES;

EID: 84908144442     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-205332     Document Type: Article

References (4)

1. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006;10:R27.
2. Spapen H, Jacobs R, Gorp VV, et al. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14.
3. Michalopoulos AS, Falagas ME. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care 2011;1:30.
4. Lindesmith LA, Baines D Jr, Bigelow DB, et al. Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med 1968;68:318-27.